Navigation Links
Advantage Phencyclidine (PCP)Card

ProductsAdvantage Phencyclidine (PCP)Card
Company Inverness Medical Innovations
Item Advantage Phencyclidine (PCP)Card
Features 
  • Professional Use Only
  • In-Vitro Diagnostic and Forensic Use.
  • Description The ADC drugs of abuse tests are highly accurate in detecting the presence of drugs at the SAMHSA recommended cut-off as confirmed by GC/MS testing. The assay provides a preliminary test result. A more specific alternative method (such as GC/MS) must be used in order to obtain a confirmed result. Professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.
    Info Inverness Medical Innovations
    Customer Service: 800-257-9525
    Web site: http://www.invernessmedical.com/

    Related medicine products :

    1. XL Advantage 3.5x @ 34cm working distance
    2. XL Advantage Prismatic
    3. XL Advantage 3.5x @ 46cm working distance
    4. XL Advantage 4.5x @ 34cm working distance
    5. XL Advantage 4.5x @ 42cm working distance
    6. XL Advantage 4.5x @ 46cm working distance
    7. XL Advantage 5.5x @ 34cm working distance
    8. XL Advantage 5.5x @ 42cm working distance
    9. XL Advantage 5.5x @ 46cm working distance
    10. MultiWash Advantage
    11. XL Advantage
    Castroviejo tying forceps, straight.
    Mac Pherson titanium tying forceps are ergonomic, very thin, angled with tying platforms. Round ergonomic design for great balance and feel. Fine platforms excellent for tying 10-0 suture.
    Harms tying forceps, standard, straight with smooth jaws. For 7-0 to 9-0 sutures.
    Anis tying forcep is extra delicate with smooth jaws, curved. For 9-0 to 11-0 sutures.
    Medicine Products:
    (Date:11/20/2008)...e results in review of national program , ...al cancer screening detects 40 percent of cancers ...ve, say Finnish Cancer Registry researchers. , ...ermine how sensitive Finland,s colorectal cancer s...isease. Half the people were assigned to a screeni...
    (Date:11/20/2008)... of researchers at Duke University Medical Center ...found that lactic acid is an important energy sour...iscovered a new way to destroy the most hard-to-ki...delivering lactic acid. , "We have known for m...ls cause resistance to radiation therapy," said se...
    (Date:11/20/2008)...supported clean-water,campaign known as the TAP P...ufacturer, The Watergeeks Laboratories, will becom... the third year of this award-winning, life-saving... children around the world. , Beginning Nov...donate a,percentage of the on-line retail price o...
    (Date:11/20/2008)...Velocity hearing instrument sales. , , SALT...c Innovations, Inc. (Nasdaq: SNCI ) announced th...dation (AFF) during a check presentation today wit...holm and AFF President and Executive Director Patr... the result of a program conducted by Sonic Innova...
    Breaking Medicine News(10 mins):Health News:Colorectal Cancer Screens Detect Unrecognized Disease 2Health News:Lactic acid found to fuel tumors 2Health News:TAP Project Partners With Watergeeks for 2009 Clean Water Campaign 2Health News:TAP Project Partners With Watergeeks for 2009 Clean Water Campaign 3Health News:Sonic Innovations Presents Donation to the Armed Forces Foundation 2Health News:Sonic Innovations Presents Donation to the Armed Forces Foundation 3
    ...ts in south western England forces many in need of...registered under an NHS dentist//. A new patient f...iles away, to locate a dentist at Northam, near B... living in Cornwall, situated 50 miles away from N...
    ...as probably acquired a misleading connotation, bei...ions//, while actually the syndrome is caused by a...sight. The term "sick building syndrome" popularl...anifested as problems with the eyes, skin, respira...
    ...r measuring about 10 kg has been removed from a fe...town of Gospic//. The woman, 66, was brought to t...severe stomach pain for several days. Doctors said...tumour that had virtually filled most of her abdom...
    ... for help towards chiropractors and osteopaths to ...y that spinal manipulation// is of no or little he...ed by experts from Peninsula Medical School in Dev...rnal of the Royal Society of Medicine. The researc...
    Other Medicine News:Health News:Job Stress, causes build up of ‘Sick building Syndrome 2
    (Date:11/20/2008)...e-USNewswire/ -- The following is being released b... WHAT: World AIDS Day Audio Media Conference ,... , 11:00 a.m. EST , Call-in number: 1-800-94...readytalk.com/r/1xe41i2yre8rs , , WHY: W...ple newly put on treatment worldwide, advocates ar...
    (Date:11/20/2008)...ELPHIA, Nov. 20 GlaxoSmit...ted States Food and Drug Administration (FDA) gran...pag) for the treatment of thrombocytopenia in pati...enic purpura (ITP) who have had an insufficient re...nectomy. The approval is a significant milestone f...
    (Date:11/20/2008)...mber 20 Arpida (SWX:,AR...Advisory Committee of the,U.S. Food and Drug Admi...proval of intravenous iclaprim, an antibiotic curr...s with complicated skin and skin structure infecti...in-resistant Staphylococcus,aureus (MRSA). , ...
    (Date:11/20/2008)...RNewswire-FirstCall/ -- Bionovo, Inc.,(Nasdaq: ...from the Phase 1B,clinical trial of their lead dr...r, BZL101, at the Society for Integrative Oncology...rgia. The Company,s oral presentation was selecte... as a part of the Best of the,SIO Session on Nove...
    Breaking Medicine Technology:Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5China Sky One Medical Inc Starts Production at Newly Acquired Facility and Reaffirms Guidance 8252 1China Sky One Medical Inc Starts Production at Newly Acquired Facility and Reaffirms Guidance 8252 2China Sky One Medical Inc Starts Production at Newly Acquired Facility and Reaffirms Guidance 8252 3NewCardio Management to Host Conference Call on October 21 8249 1NewCardio Management to Host Conference Call on October 21 8249 2NewCardio Management to Host Conference Call on October 21 8249 3Frost 26 Sullivan Acknowledges Syntec Optics Unwavering Focus on Innovation and Strategies to Improve Profitability 27339 1Frost 26 Sullivan Acknowledges Syntec Optics Unwavering Focus on Innovation and Strategies to Improve Profitability 27339 2Frost 26 Sullivan Acknowledges Syntec Optics Unwavering Focus on Innovation and Strategies to Improve Profitability 27339 3Frost 26 Sullivan Acknowledges Syntec Optics Unwavering Focus on Innovation and Strategies to Improve Profitability 27339 4Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington D C 27334 1Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington D C 27334 2Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington D C 27334 3Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington D C 27334 4